For research use only. Not for therapeutic Use.
NH₂-methylpropanamide-Exatecan TFA(CAT: I040763) is a derivative of Exatecan, a potent topoisomerase I inhibitor, modified with an NH₂-methylpropanamide linker and typically supplied as a trifluoroacetic acid (TFA) salt. This compound is designed for use in the development of antibody-drug conjugates (ADCs) and other targeted cancer therapies. The methylpropanamide linker offers enhanced stability and modifiability, enabling site-specific conjugation to carrier molecules such as antibodies or polymers. The Exatecan core retains its ability to interfere with DNA replication, inducing DNA damage and apoptosis in rapidly dividing tumor cells. It is a valuable intermediate in precision oncology research and ADC payload design.
| CAS Number | 1817857-35-4 |
| Synonyms | (2S)-3-amino-N-[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]-2-methylpropanamide;2,2,2-trifluoroacetic acid |
| Molecular Formula | C30H30F4N4O7 |
| Purity | ≥95% |
| IUPAC Name | (2S)-3-amino-N-[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]-2-methylpropanamide;2,2,2-trifluoroacetic acid |
| InChI | InChI=1S/C28H29FN4O5.C2HF3O2/c1-4-28(37)17-7-21-24-15(10-33(21)26(35)16(17)11-38-27(28)36)23-19(32-25(34)12(2)9-30)6-5-14-13(3)18(29)8-20(31-24)22(14)23;3-2(4,5)1(6)7/h7-8,12,19,37H,4-6,9-11,30H2,1-3H3,(H,32,34);(H,6,7)/t12-,19-,28-;/m0./s1 |
| InChIKey | MSMQTDLIKIFXGT-WXVOAYBSSA-N |
| SMILES | CCC1(C2=C(COC1=O)C(=O)N3CC4=C5C(CCC6=C5C(=CC(=C6C)F)N=C4C3=C2)NC(=O)C(C)CN)O.C(=O)(C(F)(F)F)O |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
